UK Hospital Trials 60-Second Test for Winter Respiratory Infections
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
A virtual care study by UMass Chan Medical School is comparing the accuracy of at-home COVID-19 and flu tests to lab-based PCR tests.
Investigators adapted a cancer detection method to identify tiny amounts of intact SARS-CoV-2 viral particles in blood and other fluids.
Researchers developed a new surveillance technique that can detect emerging COVID variants before they become widespread.
Read MoreHealgen Scientific’s Rapid Check COVID-19/Flu A&B Antigen Test received FDA De Novo authorization for OTC use.
Read MoreThe new testing system uses Janus particles to rapidly detect viral proteins, with potential applications extending beyond COVID.
Read MoreHealgen Scientific launched the manufacturing facility to help produce the Healgen Rapid Check COVID-19/Flu A&B Antigen Test.
Read MoreThe landscape of respiratory virus testing has evolved rapidly, driven by burgeoning diagnostic solutions like multiplex testing.
Read MoreA new study found routine lab tests may not effectively diagnose long COVID, underscoring the need for new biomarkers and diagnostic tools.
Read MoreResearchers have developed a bioelectric device using biomembranes to quickly detect and classify harmful variants of coronavirus.
Read MoreWatmind USA received FDA Emergency Use Authorization for its rapid OCT SpeedySwab Covid + FLU A&B Self-Test.
Read MoreA new study found that at-home antibody tests can effectively detect inadequate COVID immunity, aiding decisions about booster vaccinations.
Read MoreThe FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read MoreiHealth Labs received FDA Emergency Use Authorization for its COVID-19/Flu A&B Rapid Test Kit, enabling quick self-testing at home.
Read MoreThe lab-developed test will help diagnose Long COVID and is aimed to provide accurate insights into personalized treatment approaches.
Read MoreThe COVID test is cleared for those aged 14 or older when self-testing, and those aged two and older when administered by an adult.
Read MoreResearchers have discovered a potential way to predict which patients are likely to suffer long-haul COVID and associated lung problems.
Read MoreResearchers found that proteins regulating plasminogen-plasmin levels can be used as biomarkers to identify those at risk or severe COVID.
Read More